MiNK Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
INKT on Nasdaq
Location
149 Fifth Avenue, Suite 500, New York, NY

There are no Buy or Sell transactions made by insiders since 4/22/2024

MiNK Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Agenus Inc 10%+ Owner $22.6M Oct 12, 2023
Garo H. Armen Director $2.05M May 5, 2023
Brian Corvese Director $393K Mar 3, 2025
Ulf WIInberg Director $385K Mar 3, 2025
Jennifer Buell Chief Executive Officer $241K Jan 18, 2024
Barbara Ryan Director $150K Mar 3, 2025
Peter Behner Director $134K Mar 3, 2025
Christine Klaskin Treasurer $57.9K Oct 13, 2021
John Baldoni Director $42.8K Sep 1, 2023
Robert Peter Kadlec Director $24.3K Mar 3, 2025
Antonius van Dijk Chief Scientific Officer Jan 16, 2024
Walter Md Flamenbaum Director Oct 13, 2021

Recent Insider Transactions by Companies or Individuals for MiNK Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.